Cefroxadine (CGP-9000; CXD), 7,8[D-2-amino-2-(1,4-cyclohexadienyl)-acetamido]-3-methoxy-ceph-3-em-carboxylic acid, is a new orally active cephalosporin derivative. The spectrum of antibacterial activity of CXD is identical with that of cephalexin (CEX), but CXD was twofold more effective than CEX against Escherichia coli and Klebsiella pneumoniae. CXD was as stable to penicillinase as CEX, but it was hydrolyzed by cephalosporinase, with a relative rate of hydrolysis similar to that of CEX. The effect of inoculum size was determined by means of a twofold serial agar dilution method on HI agar. The inocula were overnight cultures diluted in physiological saline to 10-1, 10-3, and 10-5.
adienyl)-acetamido]-3-methoxy-ceph-3-em-carboxylic acid, is an orally active cephalosporin derivative ( Fig.  1 ) which was synthesized in the Research Laboratories, Pharmaceuticals Division, CIBA-GEIGY Limited, Basel, Switzerland. Other antibiotics were commercial products.
Test strains. Strains stocked in this laboratory were used as standard stock cultures and are from the Reference Laboratory of Drug-Resistant Bacteria, Gunma University. They were originally isolated from clinical materials.
Media. Heart infusion (HI) agar (Eiken), HI broth (Eiken), and antibiotic medium no. 3 (Difco) were used. Other media were peptone water and medium B. The former consisted of 10 g of polypeptone, 5 g of NaCl, and 1 liter of distilled water, the latter contained 2 g of yeast extract, 10 g of polypeptone, 7 g of Na2HPO4. 12H20, 2 g of KH2PO4, 1.2 g of glucose, and 0.4 g of MgSO4-7H20 in 1 liter of distilled water.
In vitro antibacterial activity. Minimal inhibitory concentration (MIC) of a drug was determined by an agar dilution method. Overnight culture in peptone water was diluted to 106 cells per ml with fresh peptone water. A loopful (about 0.005 ml) of diluted culture was inoculated by Micro-planter (Kubota, Japan) onto agar plates containing a series of serial twofold dilutions of a drug. MIC values were scored after overnight incubation at 37°C.
The effect of inoculum size was determined by means of a twofold serial agar dilution method on HI agar. The inocula were overnight cultures diluted in physiological saline to 10-1, 10-3, and 10-5.
The 50% infective dose. Values for 50% infective dose were determined by the method of Kato et al. (2) . A bacterial culture in peptone water was diluted to 2 x 103 to 3 x 103 cells per ml with fresh peptone water. HI agar plates containing various concentrations of a drug were prepared, and a 0.1-ml sample of diluted bacterial suspension was spread on each plate. After overnight incubation at 37°C the number of colonies that had grown on the plate were counted. The mean growth inhibition was calculated from a mean number of colonies on five plates at each drug concentration and on five drug-free agar plates. The determination of 50% infective dose with CXD and CEX was carried out against E. coli ML4707 and K. pneumoniae GN6445 (Fig. 3) Linearity was observed over a drug concentration range that inhibited from 5 to 95% of the bacterial growth. The 50% infective doses for CXD and CEX against E. coli ML4707 were 1.2 and 3.9 ,ug/ml, respectively. Against K. pneumoniae GN6445, the 50% infective doses of CXD and CEX were 1.45 and 2.15 ,ug/ml, respectively. Therefore, CXD is more effective in vitro against E. coli ML4707 and K. pneumoniae GN6445 than is CEX.
The effect of inoculum size on antibacterial activity of CXD and CEX against clinical isolates of E. coli is shown in Table 2 lates ofE. coli and K. pneumoniae are illustrated in Fig. 4 . Ninety-eight percent of the E. coli strains were inhibited by CXD at a concentration of 6.25 ,ug/ml, as compared to 50% of the strains inhibited by CEX at the same antibiotic concentration. The bactericidal effectiveness of CXD was also more pronounced than that of CEX; CXD affected 80% of the strains at the same concentration, as compared to only 20% affected by CEX. In the case of K. pneumoniae, the percentage of isolates inhibited by CXD was twofold larger than that by CEX, and the percentage of isolates killed by CXD was also about twofold larger than that by CEX. Bactericidal activity of CXD against E. coli ML4707 was examined by counting viable cells (Fig. 5) . When the culture reached a density of approximately 104 cells per ml, from one-fourthto fourfold the MICs of CXD and CEX were added, and incubation was continued. After 4 h of incubation, both drugs reduced the number of viable cells to 102 at concentrations of one-to fourfold the MIC. CXD had more bactericidal activity than CEX against E. coli ML4707 ( was no difference in the affinities to PBP-2, -3, -4, and -5/6 between CXD and CEX. In vivo antibacterial activity. Chemotherapeutic effects of CXD on experimental infections of mice with E. coli ML4707 and K. pneumoniae GN6445 are shown in Table 4 . With both strains, CXD was more effective. Although CXD had MICs almost equal to those of CEX, the protective activity of CXD in experimental infection in mice was greater than that of CEX. DISCUSSION PBP-lBs of E. coli is reported to be involved in the cross-linking reaction of cell wall peptidoglycan (11) . The lack of PBP-1A alone in E. coli does not affect cell growth, because this protein is supposed to be a detour enzyme-carrying function compensating for the lack of PBPlBs (11) . PBP-2 is supposed to be involved in maintaining the cell shape (8, 9) , and PBP-3 is supposed to be concerned in septum formation (8) . PBP-4 is identical to D-alanme carboxypeptidase IB (1, 5) , and PBP-5/6 corresponds to Dalanine carboxypeptidase IA (4, 10) . Therefore, in view of the affinity of CXD to PBP-lBs, it seems likely that CXD has more intensive lytic activity than CEX.
